Implementing NICE guidelines on risk assessment for venous thromboembolism

International Journal of Health Care Quality Assurance - Tập 25 Số 7 - Trang 618-624 - 2012
DushanThavarajah1, MartinWetherill2
1Department of Trauma and Orthopaedics, The Royal Berkshire Hospital, Reading, UK
2Department of Trauma and Orthopaedics, Milton Keynes General Hospital, Milton Keynes, UK

Tóm tắt

PurposeVenous thromboembolism (VTE) prophylaxis guidelines were originally published by the National Institute of Clinical Excellence (NICE) in April 2007. Controversy eclipsed their release. Consequently, the VTE prophylaxis publication was reviewed and republished in January 2010. The NICE guidelines recommend that all patients are assessed for risk before pharmacological prophylaxis is offered and reassessed at 24 hours to check adverse reactions; and that prophylaxis is appropriate. This paper aims to look at their implementation.Design/methodology/approachA prospective audit and re‐audit in one orthopaedic department was completed to see how well the new guidelines were adhered to, find out first‐hand what problems there were, and how they might be remedied.FindingsAudit and re‐audit highlighted that attaching an assessment tool to drug charts is plausible.Research limitations/implicationsThe study was limited to one centre and used a relatively weak research design.Practical implicationsAs a process, the clinical impact of risk assessment for VTE is questionable as many patients will be high risk. Removing reassessment at 24 hours from the NICE guidance is recommended.Originality/valueThe authors put the NICE guideline into clinical practice, demonstrating how effectively it can work with their method, but also highlighting its flaws.

Từ khóa


Tài liệu tham khảo

Cusick, L.A. and Beverland, D. (2009), “The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients”, Journal of Bone and Joint Surgery (British), Vol. 91‐B No. 5, pp. 645‐8.

House of Commons Health Committee (2005), The Prevention of Venous Thromboembolism in Hospitalised Patients, The Stationery Office, London.

Jameson, S.S., Bottle, A., Malviya, A., Muller, S.D. and Reed, M.R. (2010), “The impact of national guidelines for the prophylaxis of venous thromboembolism on the complications of arthroplasty of the lower limb”, Journal of Bone and Joint Surgery (British), Vol. 92‐B No. 1, pp. 123‐9.

Lassen, M.R., Ageno, W. and Borris, L.C. (2008), “Rivaroxiban versus enoxaparin for thromboprophylaxis after total knee arthroplasty”, The New England Journal of Medicine, Vol. 358, pp. 2776‐86.

National Institute for Clinical Excellence (2007), The NICE Bulletin for Parliamentarians, No. 37, available at: www.nice.org.uk/niceMedia/pdf/HCE May0t.pdf (accessed July 2010).

National Institute for Clinical Excellence – Acute and Chronic Conditions (2010), “Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital”, available at: www.nice.org.uk/nicemedia/pdf/CG92FullGuideline.pdf (accessed July 2010).

Parry, M., Wylde, V. and Blom, A.W. (2008), “Ninety‐day mortality rate after elective total hip replacement: 1549 patients using aspirin as a thromboprophylactic agent”, Journal of Bone and Joint Surgery (British), Vol. 90‐B No. 3, pp. 306‐7.

Thromboembolic Risk Factors Consensus Group (THRIFT) (1992), “Risk of and prophylaxis for venous thromboembolism in hospital patients”, British Medical Journal, Vol. 305, pp. 567‐74.

Treasure, T., Chong, L.Y., Sharpin, C., Wonderling, D., Head, K. and Hill, J. (2010), “Developing guidelines for venous thromboembolism for The National Institute for Clinical Excellence”, Journal of Bone and Joint Surgery (British), Vol. 92‐B No. 5, pp. 611‐6.

Thông tin
Thông tin xuất bản

International Journal of Health Care Quality Assurance

Tập 25 Số 7

618-624

Thông tin tác giả